Coronary artery bypass grafting within 30 days of an acute myocardial infarction

T Hirotani1, T Kameda, S Shirota

  • 1Department of Cardiovascular Surgery, Tokyo Saiseikai Central Hospital, 1-7-14 Mita, Minato-ku, Tokyo 108-0073, Japan.

Insights

Coronary artery bypass grafting soon after acute myocardial infarction (AMI) carries high risks. However, using arterial grafts improves long-term survival, suggesting their use in select early post-AMI patients.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Early surgical intervention is considered for symptomatic patients post-acute myocardial infarction (AMI).
  • Coronary artery bypass grafting (CABG) shortly after AMI presents significant risks.
  • Evaluating the outcomes of early CABG after AMI is crucial.

Purpose of the Study:

  • To assess the results of coronary artery bypass grafting performed soon after an acute myocardial infarction.
  • To identify predictors of operative mortality in patients undergoing early CABG post-AMI.

Main Methods:

  • Retrospective analysis of 478 consecutive patients who underwent CABG between November 1991 and November 1999.
  • Focus on 68 patients who underwent CABG within 30 days of AMI.
  • Univariate and multivariate analyses were conducted to evaluate operative mortality predictors.

Main Results:

  • Operative mortality was significantly higher (7.4%) in patients undergoing early CABG post-AMI compared to those without (0.8%).
  • Coronary artery bypass grafting without arterial grafts was a predictor of survival.
  • Patients receiving arterial grafts showed better long-term survival than those with venous grafts alone.

Conclusions:

  • Coronary artery bypass grafting using arterial grafts, when indicated, may be performed early after AMI if hemodynamic conditions are unstable.
  • Arterial grafts are associated with improved long-term survival in early post-AMI CABG patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...